ARCHIVES

Oblimersen Combination Improves CLL Survival

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

October 18, 2013

NCI Advisory Groups To Be Cut By One-Third

April 22, 1977

Funding Opportunities: NIH seeks “visionary thinkers” for awards of $2.5 million over five years. NCI RFA available.

January 23, 2004

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

DCE Board Delays Decision On New Collaborative Groups In Chemoprevention

November 30, 1984